1. Laxmi, Aishwarya, Gupta, Pawan, Gupta, Jeena. . CCDC6, a gene product in fusion with different protoncogenes, as a potential chemotherapeutic target. In Cancer biomarkers : section A of Disease markers, 24, 383-393. doi:10.3233/CBM-181601. https://pubmed.ncbi.nlm.nih.gov/30909182/
2. Schwartzentruber, Jeremy, Cooper, Sarah, Liu, Jimmy Z, Beltrao, Pedro, Bassett, Andrew. 2021. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer's disease risk genes. In Nature genetics, 53, 392-402. doi:10.1038/s41588-020-00776-w. https://pubmed.ncbi.nlm.nih.gov/33589840/
3. Takeuchi, Kengo, Soda, Manabu, Togashi, Yuki, Mano, Hiroyuki, Ishikawa, Yuichi. 2012. RET, ROS1 and ALK fusions in lung cancer. In Nature medicine, 18, 378-81. doi:10.1038/nm.2658. https://pubmed.ncbi.nlm.nih.gov/22327623/
4. Luise, Chiara, Merolla, Francesco, Leone, Vincenza, Fusco, Alfredo, Celetti, Angela. 2012. Identification of sumoylation sites in CCDC6, the first identified RET partner gene in papillary thyroid carcinoma, uncovers a mode of regulating CCDC6 function on CREB1 transcriptional activity. In PloS one, 7, e49298. doi:10.1371/journal.pone.0049298. https://pubmed.ncbi.nlm.nih.gov/23145146/
5. Wu, Tianyu, Jiang, Xiaoqing, Xu, Bin, Zhang, Xin, Wang, Yu. 2022. High expression of CCDC6 in relation to unfavorable outcome and immune cells infiltration in hepatobiliary carcinoma. In Journal of Cancer, 13, 3378-3395. doi:10.7150/jca.76050. https://pubmed.ncbi.nlm.nih.gov/36186907/
6. Leone, Vincenza, Langella, Concetta, Esposito, Francesco, Celetti, Angela, Fusco, Alfredo. . Ccdc6 knock-in mice develop thyroid hyperplasia associated to an enhanced CREB1 activity. In Oncotarget, 6, 15628-38. doi:. https://pubmed.ncbi.nlm.nih.gov/25970781/
智鼠故事 
